Cargando…
CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma
The tumor microenvironment (TME) is a critical regulator of the development of malignant lymphoma. Therapeutics targeting the TME, especially immune checkpoint molecules, are changing the treatment strategy for lymphoma. However, the overall response to these therapeutics for diffuse large B‐cell ly...
Autores principales: | Higashi, Morihiro, Momose, Shuji, Takayanagi, Natsuko, Tanaka, Yuka, Anan, Tomoe, Yamashita, Takahisa, Kikuchi, Jun, Tokuhira, Michihide, Kizaki, Masahiro, Tamaru, Jun‐ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161324/ https://www.ncbi.nlm.nih.gov/pubmed/35289116 http://dx.doi.org/10.1002/cjp2.266 |
Ejemplares similares
-
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center‐derived B‐cell lymphomas
por: Tanaka, Yuka, et al.
Publicado: (2020) -
Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma
por: Yamashita, Takahisa, et al.
Publicado: (2020) -
Rapid deterioration of intravascular large B-cell lymphoma with mass formation in the trigeminal nerve and multiple organ infiltration: An autopsy case report
por: Tanaka, Yuka, et al.
Publicado: (2021) -
Better method for detection of CD30: Immunohistochemistry or flow cytometry?
por: Higashi, Morihiro, et al.
Publicado: (2021) -
The clinical impact of absolute lymphocyte count in peripheral blood among
patients with methotrexate - associated lymphoproliferative disorders
por: Tokuhira, Michihide, et al.
Publicado: (2020)